Small Intestinal Carcinoma clinical trials
11 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
- Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
- CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- Integrated Cancer Repository for Cancer Research
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers
- Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
- Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Small Intestinal Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.